Abstract
Cutaneous vasculitis has been associated with both Coronavirus
disease-2019 (COVID-19), and SARS-CoV-2 vaccines. We reported a
41-year-old male who developed bullous lesions and erythematous plaques
leading to atrophic patches two weeks after injection of the second dose
of the COVID-19 vaccine. The skin biopsy showed leukocytoclastic
vasculitis. The disease was self-limited and no recurrence of symptoms
happened after six months of follow-up.